Rice Hall James & Associates, LLC Eagle Pharmaceuticals, Inc. Transaction History

Rice Hall James & Associates, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 01, 2019	SELL	$38.66 - $51.82 $874,798 - $1.17 Million	-22,628 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $77,148 - $142,300	2,101 Added 10.24%	22,628 $912,000
Q3 2018 Oct 25, 2018	SELL	$66.65 - $83.86 $995,217 - $1.25 Million	-14,932 Reduced 42.11%	20,527 $1.42 Million
Q2 2018 Aug 02, 2018	BUY	$51.25 - $76.62 $740,665 - $1.11 Million	14,452 Added 68.8%	35,459 $2.68 Million
Q1 2018 Apr 25, 2018	BUY	$52.16 - $66.86 $1.1 Million - $1.4 Million	21,007 New	21,007 $1.11 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.